Arctic Bioscience
Logotype for Arctic Bioscience

Arctic Bioscience (ABS) investor relations material

Arctic Bioscience Q4 2025 TU earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Arctic Bioscience
Q4 2025 TU earnings summary26 Feb, 2026

Executive summary

  • 2025 sales revenue was NOK 39.8 million, a decrease from 2024 due to a significant product recall at the end of 2024, but Q4 2025 saw a strong recovery with NOK 13.9 million in sales and robust order intake for 2026.

  • B2B segment remained dominant, accounting for nearly 90% of sales, with the US market showing over 140% year-over-year growth and the Americas achieving the highest revenue share at 33%.

  • Operational cost reductions of NOK 13.6 million improved EBITDA, with adjusted EBITDA for 2025 at NOK -28.3 million, up from NOK -36.8 million in 2024.

  • Pharma pipeline advanced with positive results in psoriasis and glaucoma studies, and the HeROPA trial demonstrated significant reduction in systemic inflammation, attracting international attention and partnership discussions.

  • ROMEGA® products expanded into Singapore and Asia, and Arctic Algae project received NOK 2.5 million in funding for oral fish vaccines.

Financial highlights

  • 2025 sales revenue was NOK 39.8 million, down NOK 3.7 million from 2024, with Q4 sales at NOK 13.9 million.

  • Gross margin for 2025 was 27.1%, stable compared to 2024.

  • Adjusted EBITDA for 2025 was NOK -28.3 million, an improvement from NOK -36.8 million in 2024.

  • Available liquidity at year-end was NOK 5.2 million, down from NOK 7 million at the end of 2024.

  • Operational costs reduced by NOK 13.6 million year-over-year.

Outlook and guidance

  • Strong order outlook for 2026, with expected growth in nutraceuticals and new product launches in B2B and B2C segments across Europe and Asia.

  • Continued focus on expanding B2C distribution in Europe and growing presence in Asia, including new markets like India, Japan, and Singapore.

  • Pharma development to proceed with partners and soft funding, not through direct capital raises.

  • Data from HeROPA trial to be published and presented in 2026, increasing visibility.

  • Liquidity situation is closely monitored, with ongoing dialogue with the bank and board oversight.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Arctic Bioscience earnings date

Logotype for Arctic Bioscience
Q4 20257 May, 2026
Arctic Bioscience
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Arctic Bioscience earnings date

Logotype for Arctic Bioscience
Q4 20257 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Arctic Bioscience ASA is a biotechnology company specializing in the development and production of health products derived from marine ingredients, particularly omega-3 fatty acids from herring roe. The company's products are used in the nutraceutical and pharmaceutical sectors, offering health benefits related to brain, heart, and immune function. In addition to producing omega-3-based supplements for consumer markets, Arctic Bioscience is involved in the research and development of new pharmaceutical applications utilizing marine-based bioactive compounds. The company is headquartered in Ørsta, Norway, and its shares are listed on the Oslo Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage